{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:57:29Z","timestamp":1774007849938,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022720","name":"Health Bureau","doi-asserted-by":"publisher","award":["08190456"],"award-info":[{"award-number":["08190456"]}],"id":[{"id":"10.13039\/100022720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jaut.2026.103534","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:42:41Z","timestamp":1770334961000},"page":"103534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vascular effects of achieving low disease activity in axial spondyloarthritis \u2013 A 2-year prospective treat-to-target study"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5665-1609","authenticated-orcid":false,"given":"Huan","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sze-Lok","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac T.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien PW.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley K.","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolly M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violet K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitty Y.","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac C.","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan P.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6410-8852","authenticated-orcid":false,"given":"Lai-Shan","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaut.2026.103534_bib1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/acr.24820","article-title":"All-cause and cause-specific mortality in psoriatic arthritis and ankylosing spondylitis: a systematic review and meta-analysis","volume":"75","author":"Chaudhary","year":"2023","journal-title":"Arthritis Care Res."},{"issue":"6","key":"10.1016\/j.jaut.2026.103534_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MD.0b013e3181c10773","article-title":"The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease","volume":"88","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.jaut.2026.103534_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5551\/jat.45294","article-title":"Carotid intima-media thickness in patients with ankylosing spondylitis: a systematic review and updated meta-analysis","volume":"26","author":"Yuan","year":"2019","journal-title":"J. Atherosclerosis Thromb."},{"issue":"6","key":"10.1016\/j.jaut.2026.103534_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/0003319718814309","article-title":"The relationship of ankylosing spondylitis and subclinical atherosclerosis: a systemic review and meta-analysis","volume":"70","author":"Bai","year":"2019","journal-title":"Angiology"},{"issue":"7","key":"10.1016\/j.jaut.2026.103534_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrrheum.2013.93","article-title":"Spondyloarthritis: is it time to replace BASDAI with ASDAS?","volume":"9","author":"Machado","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103534_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing spondylitis disease Activity score (ASDAS): defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jaut.2026.103534_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003488","article-title":"Moderate and high disease activity levels increase the risk of subclinical atherosclerosis progression in early rheumatoid arthritis: a 5-year prospective study","volume":"10","author":"Meng","year":"2024","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.jaut.2026.103534_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/art.40695","article-title":"Effect of achieving minimal disease activity on the progression of subclinical atherosclerosis and arterial stiffness: a prospective cohort study in psoriatic arthritis","volume":"71","author":"Cheng","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.jaut.2026.103534_bib9","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/annrheumdis-2016-210997","article-title":"Low disease activity (DAS28\u22643.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent cox regression analysis in a large cohort study","volume":"76","author":"Arts","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jaut.2026.103534_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13075-021-02695-5","article-title":"Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO","volume":"24","author":"Llop","year":"2022","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.jaut.2026.103534_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/rheumatology\/ket469","article-title":"The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis\u2014a randomized, placebo-controlled pilot trial","volume":"53","author":"Tam","year":"2014","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jaut.2026.103534_bib12","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/rheumatology\/ker434","article-title":"Anti-TNF-\u03b1 therapy may not improve arterial stiffness in patients with AS: a 24-week follow-up","volume":"51","author":"Capkin","year":"2012","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.jaut.2026.103534_bib13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/rheumatology\/ken198","article-title":"Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease","volume":"47","author":"Mathieu","year":"2008","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jaut.2026.103534_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/annrheumdis-2013-203934","article-title":"Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis","volume":"74","author":"van Sijl","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jaut.2026.103534_bib15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajh.2012.12","article-title":"Effect of 1-year anti-TNF-\u03b1 therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study","volume":"25","author":"Angel","year":"2012","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"10.1016\/j.jaut.2026.103534_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jaut.2026.103534_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.62.2.127","article-title":"Assessment of enthesitis in ankylosing spondylitis","volume":"62","author":"Heuft-Dorenbosch","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jaut.2026.103534_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.jaut.2026.103534_bib19","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.jaut.2026.103534_bib20","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.jaut.2026.103534_bib21","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index","volume":"21","author":"Calin","year":"1994","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.jaut.2026.103534_bib22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/annrheumdis-2013-203967","article-title":"Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS","volume":"74","author":"Kiltz","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.jaut.2026.103534_bib23","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3899\/jrheum.171128","article-title":"Effect of treat-to-target strategies aiming at remission of arterial stiffness in early rheumatoid arthritis: a randomized controlled study","volume":"45","author":"Tam","year":"2018","journal-title":"J. Rheumatol."},{"issue":"Pt 1","key":"10.1016\/j.jaut.2026.103534_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1469-7793.2000.t01-1-00263.x","article-title":"The influence of heart rate on augmentation index and central arterial pressure in humans","volume":"525","author":"Wilkinson","year":"2000","journal-title":"J. Physiol."},{"issue":"10","key":"10.1016\/j.jaut.2026.103534_bib26","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s10067-023-06655-z","article-title":"Cardiovascular risk in axial spondyloarthritis-a systematic review","volume":"42","author":"Hintenberger","year":"2023","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.jaut.2026.103534_bib27","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/annrheumdis-2020-219585","article-title":"Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial","volume":"80","author":"Molto","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.jaut.2026.103534_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/acr.20408","article-title":"Population\u2010based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis","volume":"63","author":"Bremander","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2026.103534_bib29","series-title":"Seminars in Arthritis and Rheumatism","first-page":"140","article-title":"No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis\u2014a retrospective cohort study using routine data","author":"Brophy","year":"2012"},{"issue":"2","key":"10.1016\/j.jaut.2026.103534_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/03009742.2013.822097","article-title":"A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis","volume":"43","author":"Chou","year":"2014","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103534_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00296-013-2927-5","article-title":"Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population","volume":"34","author":"Chen","year":"2014","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.jaut.2026.103534_bib32","doi-asserted-by":"crossref","first-page":"C780","DOI":"10.1152\/ajpcell.00153.2023","article-title":"Inducible nitric oxide synthase activity mediates TNF-\u03b1-induced endothelial cell dysfunction","volume":"325","author":"Liu","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.jaut.2026.103534_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4236\/wjcd.2019.94024","article-title":"Targeting the inflammation culprit in patients with psoriasis\/psoriatic arthritis and associated cardiovascular comorbidities. Is the IL-17 inhibitor the new kid on the block?","volume":"9","author":"Pater","year":"2019","journal-title":"World J. Cardiovasc. Dis."},{"key":"10.1016\/j.jaut.2026.103534_bib34","article-title":"Interleukin-17 links inflammatory cross-talks between comorbid psoriasis and atherosclerosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2026.103534_bib35","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/acr.23567","article-title":"Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis","volume":"70","author":"Lauper","year":"2018","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2026.103534_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152477","article-title":"Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: a population-based study","volume":"67","author":"Shi","year":"2024","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jaut.2026.103534_bib37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00296-023-05528-7","article-title":"Progression of subclinical atherosclerosis in ankylosing spondylitis: a 10-year prospective study","volume":"44","author":"Arida","year":"2024","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.jaut.2026.103534_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00296-021-05067-z","article-title":"Advances in treatment of axial spondyloarthritis are associated with improved patient outcomes: data from the ankylosing spondylitis registry of Ireland (ASRI)","volume":"42","author":"Maguire","year":"2022","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.jaut.2026.103534_bib39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semarthrit.2008.01.012","article-title":"Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis","volume":"38","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jaut.2026.103534_bib40","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.30265","article-title":"Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis","volume":"63","author":"Evans","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jaut.2026.103534_bib41","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3899\/jrheum.160053","article-title":"Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis","volume":"43","author":"Ikdahl","year":"2016","journal-title":"J. Rheumatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:36:50Z","timestamp":1773999410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"alternative-id":["S0896841126000120"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103534","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular effects of achieving low disease activity in axial spondyloarthritis \u2013 A 2-year prospective treat-to-target study","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103534"}}